Drugs / Grass pollen allergens
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00841256 | Feb 2008 → Jun 2012 | allergic rhinitis | Allergopharma GmbH & Co. KG | Completed | Met primary |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Grass pollen allergens | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00841256 ↗ |